Prot #QRL-201-01: A Multi-center, Randomized, Double-blind, Placebo-controlled Multiple-ascending Dose Study to Evaluate the Safety and Tolerability of Qrl-201 in Amyotrophic Lateral Sclerosis

Project: Research project

Project Details

StatusFinished
Effective start/end date4/6/2310/6/24

Funding

  • Worldwide Clinical Trials, Inc. (Prot #QRL-201-01 // Prot #QRL-201-01)
  • QurAlis Corporation (Prot #QRL-201-01 // Prot #QRL-201-01)